Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT01390818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor
Metastatic Solid Tumor
Breast Cancer
Non Small Cell Lung Cancer
Melanoma
Colorectal Cancer

Interventions

DRUG: MSC1936369B (pimasertib)
DRUG: SAR245409 (PI3K and mTOR inhibitor)
DRUG: MSC1936369B (pimasertib)
DRUG: SAR245409 (PI3K and mTOR inhibitor)

Sponsor

EMD Serono

Collaborators

[object Object]